Vimarsana
Biggest News Aggregation in the World

Page 3 - Sarcoma Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarcoma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarcoma Program Today - Breaking & Trending Today

Advice and Future Directions for the Treatment of GIST - Vimarsana News

Advice and Future Directions for the Treatment of GIST

Edwin Choy, MD, provides key recommendations for community oncologists treating patients with gastrointestinal stromal tumor.

Three Nonprofit Organizations Step Up to Fund Unique, Pediatric Cancer Clinical Trial - Johns Hopkins All Children's Hospital - Vimarsana News

Three Nonprofit Organizations Step Up to Fund Unique, Pediatric Cancer Clinical Trial - Johns Hopkins All Children's Hospital

The study will be the first to use tumor infiltrating lymphocyte therapy to address certain pediatric cancers.

Ayala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumors - Vimarsana News

Ayala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumors

Ayala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumors - read this article along with other careers information, tips and advice on BioSpace

Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas - Vimarsana News

Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas

HOUSTON, Aug. 04, 2022 -- Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options, announces the... | August 4, 2022

Preliminary Results Presented at ASCO Demonstrated Promising Clinical Efficacy with Unesbulin in Leiomyosarcoma Study - Vimarsana News

Preliminary Results Presented at ASCO Demonstrated Promising Clinical Efficacy with Unesbulin in Leiomyosarcoma Study

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced encouraging preliminary safety and efficacy results from its Phase 1B study of unesbulin...